MINERVAX ApS: Financial statements 2012
CVR: 32673287
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
MINERVAX ApS (CVR 32673287) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -1,060,392 and a net result of DKK -845,708. Equity in the 2012 report amounted to DKK 1,427,220. The solvency ratio was 85.2%.
- Gross Profit
- DKK -1,060,392
- Profit/Loss
- DKK -845,708
- Equity
- DKK 1,427,220
- Total Assets
- DKK 1,674,958
Official annual report
Keep an eye on MINERVAX ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of January 1, 2012, ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of MINERVAX ApS.
As of January 1, 2012, VERAX has stepped down as auditor of MINERVAX ApS.
About MINERVAX ApS
MINERVAX ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Per Bo Pedersen Fischer. The board consists of Veronica Gambillara Fonck (chair), Bita Sehat, Christopher J. Gagliardi and Emmanuelle Coutanceau. The company's owners include Novo Holdings A/S, SUNSTONE LIFE SCIENCE VENTURES FUND III K/S and Wellington Partners Life Sciences V GmbH & Co. KG. The company has 2 employees (2018). In 2025, the company reported a net result of EUR -31,530,000 compared with EUR -29,126,000 the year before. Equity in the 2025 report amounted to EUR 9,787,000.